Infinity Pharmaceuticals (NASDAQ:INFI) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research note issued on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, Piper Sandler reiterated a “neutral” rating on shares of Infinity Pharmaceuticals in a research report on Friday, February 24th. Infinity Pharmaceuticals Price Performance Shares […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Piper Sandler ,Matthewd Shair ,Stevenh Holtzman ,Renaissance Technologies ,Millennium Management ,Hedge Funds Weigh In On Infinity Pharmaceuticals ,Mirabella Financial Services ,Infinity Pharmaceuticals Price Performance ,Infinity Pharmaceuticals Inc ,Charles Schwab Investment Management Inc ,News Ratings For Infinity Pharmaceuticals Daily ,Infinity Pharmaceuticals ,Get Rating ,Schwab Investment Management ,Street Corp ,Financial Services ,Infinity Pharmaceuticals Daily ,Nasdaq Infi ,Infi ,Medical ,45665g30 ,Initiated Coverage ,Stocknews Com ,